Behçet’s disease in Egypt: a multicenter nationwide study on 1526 adult patients and review of the literature
The present work was conducted to estimate the prevalence of adult Behçet’s disease (BD) in adult Egyptian and to study the clinical pattern and influence of age at-onset and sex on disease phenotype. Also, we investigated the spectrum of presentation and frequencies along the north-to-south gradient of the country.
Patients and method
The population-based, multicenter, cross-sectional study included 1526 adult BD patients from 26 specialized Egyptian rheumatology centers. Demographic, clinical, and therapeutic data are assessed for all patients.
The mean age of patients was 35.7 ± 9.84 years, disease duration 6.58 ± 5.25 years, and age at onset 29.37 ± 8.6 years; 91 were juvenile-onset (JoBD). There were 1102 males and 424 females (M:F 2.6:1). Regarding co-morbidities, 19.92% were diabetic, and 26.05% were hypertensive. The mean body mass index was 27.57 ± 5.24 (43.1% overweight; 25.9% obese). The mean BD current activity form was 4.48 ± 4.28. Regarding the medications use, systemic steroid and colchicine were the most common drugs used (947 (90.2%) and 611 (82.7%), respectively). The overall estimated prevalence of BD in Egypt was 3.6/100,000 population being highest in the two main cities: Alexandria (15.27) and Cairo (8.72). Pathergy test was positive in 43.4%. 90.2% were receiving systemic steroids and 8.3%, biologics. Disease characteristics were comparable between JoBD and adult-onset BD cases. Central nervous system (CNS), deep venous thrombosis (DVT), and gastrointestinal (GIT) involvement were significantly higher in males (p = 0.01, p = 0.001, and p = 0.001 respectively) while joint affection (p = 0.001) and disease activity (p = 0.011) were increased in females.
This study provides current prevalence of BD in Egypt; 3.6/100,000 with no remarkable north-to-south gradient. The sex influences the disease phenotype with the CNS, DVT, and GIT involvement are higher in males, while the joint affection and disease activity were increased in females.
• The prevalence and phenotype of Behçet’s disease across Egypt is presented in a multicenter nationwide study.
• The potential influence of the age at onset and sex on disease phenotype is highlightened.
• A review of the literature worldwide is presented allowing comparisons with studies from other nations.
KeywordsAge at onset Behçet’s disease Egypt Multicenter Prevalence Sex
Compliance with ethical standards
- 1.Gallizzi R, Pidone C, Cantarini L, Finetti M, Cattalini M, Filocamo G, Insalaco A, Rigante D, Consolini R, Maggio MC, Civino A, Martino S, Olivieri AN, Fabio G, Pastore S, Mauro A, Sutera D, Trimarchi G, Ruperto N, Gattorno M, Cimaz R (2017) A national cohort study on pediatric Behcet’s disease: cross-sectional data from an Italian registry. Pediatr Rheumatol Online J 15:84. https://doi.org/10.1186/s12969-017-0213-x CrossRefGoogle Scholar
- 5.Davatchi F, Chams-Davatchi C, Shams H, Shahram F, Nadji A, Akhlaghi M, Faezi T, Ghodsi Z, Sadeghi Abdollahi B, Ashofteh F, Mohtasham N, Kavosi H, Masoumi M (2017) Behcet’s disease: epidemiology, clinical manifestations, and diagnosis. Expert Rev Clin Immunol 13:57–65. https://doi.org/10.1080/1744666X.2016.1205486 CrossRefGoogle Scholar
- 7.Davatchi F, Chams-Davatchi C, Ghodsi Z, Shahram F, Nadji A, Shams H, Akhlaghi M, Larimi R, Sadeghi-Abdolahi B (2011) Diagnostic value of pathergy test in Behcet’s disease according to the change of incidence over the time. Clin Rheumatol 30:1151–1155. https://doi.org/10.1007/s10067-011-1694-5 CrossRefGoogle Scholar
- 8.Ishido T, Horita N, Takeuchi M, Kawagoe T, Shibuya E, Yamane T, Hayashi T, Meguro A, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Ishigatsubo Y, Takeno M, Kurosawa M, Kaneko T, Mizuki N (2017) Clinical manifestations of Behcet’s disease depending on sex and age: results from Japanese nationwide registration. Rheumatology (Oxford) 56:1918–1927. https://doi.org/10.1093/rheumatology/kex285 CrossRefGoogle Scholar
- 13.Egypt 2018: Statistical abstract (2018) Central Agency for Public Mobilization and Statistics (CAPMAS). June. https://www.capmas.gov.eg/HomePage.aspx#
- 15.Kappen JH, van Dijk EHC, Baak-Dijkstra M, van Daele P, Lam-Tse WK, van Hagen P, van Laar J (2015) Behcet’s disease, hospital-based prevalence and manifestations in the Rotterdam area. Neth J Med 73:471–477Google Scholar
- 18.Mahr A, Belarbi L, Wechsler B, Jeanneret D, Dhote R, Fain O, Lhote F, Ramanoelina J, Coste J, Guillevin L (2008) Population-based prevalence study of Behcet’s disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum 58:3951–3959. https://doi.org/10.1002/art.24149 CrossRefGoogle Scholar
- 19.Assaad-Khalil SH, Kamel FA, Ismail EA (1997) Starting a regional registry for patients with Behçet’s disease in North West Nile Delta region in Egypt. In: Hamza M, editor. Behçet’s Disease. Tunis: Pub Adhoua 173–176Google Scholar
- 23.Dia D, Dieng MT, Sy Ndiaye T, Fall S, Ndongo S, Diallo M, Moreira Diop T, Labou A, Ndiaye B (2003) Behcet’s disease in Dakar (Senegal): epidemiological and clinical features. Dakar Med 48:64–67Google Scholar
- 24.Yurdakul S, Gunaydin I, Tuzun Y et al (1988) The prevalence of Behcet’s syndrome in a rural area in northern Turkey. J Rheumatol 15:820–822Google Scholar
- 25.Cakir N, Dervis E, Benian O, Pamuk ON, Sonmezates N, Rahimoglu R, Tuna S, Cetin T, Sarikaya Y (2004) Prevalence of Behcet’s disease in rural western Turkey: a preliminary report. Clin Exp Rheumatol 22:S53–S55Google Scholar
- 26.Suzuki T, Horita N, Takeuchi M, Ishido T, Mizuki Y, Mizuki R, Kawagoe T, Shibuya E, Yuta K, Yamane T, Hayashi T, Meguro A, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Fukumoto T, Ishigatsubo Y, Kurosawa M, Takeno M, Kaneko T, Mizuki N (2018) Clinical features of early-stage possible Behcet’s disease patients with a variant-type major organ involvement in Japan. Mod Rheumatol:1–7. https://doi.org/10.1080/14397595.2018.1494501
- 28.Kim JN, Kwak SG, Choe J-Y, Kim S-K (2017) The prevalence of Behcet’s disease in Korea: data from Health Insurance Review and Assessment Service from 2011 to 2015. Clin Exp Rheumatol 35(Suppl 1):38–42Google Scholar
- 30.Madanat WY, Alawneh KM, Smadi MM et al (2017) The prevalence of Behcet’s disease in the north of Jordan: a hospital-based epidemiological survey. Clin Exp Rheumatol 35(Suppl 1):51–54Google Scholar
- 31.Lennikov A, Alekberova Z, Goloeva R, Kitaichi N, Denisov L, Namba K, Takeno M, Ishigatsubo Y, Mizuki N, Nasonov E, Ishida S, Ohno S (2015) Single center study on ethnic and clinical features of Behcet’s disease in Moscow, Russia. Clin Rheumatol 34:321–327. https://doi.org/10.1007/s10067-013-2442-9 CrossRefGoogle Scholar
- 33.Olivieri I, Leccese P, Padula A, Nigro A, Palazzi C, Gilio M, D'Angelo S (2013) High prevalence of Behçet’s disease in southern Italy. Clin Exp Rheumatol 31:28–31Google Scholar
- 34.Bonitsis NG, Luong Nguyen LB, LaValley MP et al (2015) Gender-specific differences in Adamantiades-Behcet’s disease manifestations: an analysis of the German registry and meta-analysis of data from the literature. Rheumatology (Oxford) 54:121–133. https://doi.org/10.1093/rheumatology/keu247 CrossRefGoogle Scholar
- 35.Rodríguez-Carballeira M, Alba MA, Solans-Laqué R, Castillo MJ, Ríos-Fernández R, Larrañaga JR, Martínez-Berriotxoa A, Espinosa G, REGEB investigators (2014) Registry of the Spanish network of Behçet’s disease: a descriptive analysis of 496 patients. Clin Exp Rheumatol 32:S33–S39Google Scholar
- 42.Petty RE, Cabral DA (2016) Chapter 32 - Vasculitis and Its Classification. In: Petty RE, Laxer RM, Lindsley CB (eds) Wedderburn LRBT-T of PR, 7th edn. W.B. Saunders, Philadelphia, pp 448–451.e1Google Scholar
- 45.Lee YB, Lee SY, Choi JY, Lee JH, Chae HS, Kim JW, Han KD, Park YG, Yu DS (2018) Incidence, prevalence, and mortality of Adamantiades-Behcet’s disease in Korea: a nationwide, population-based study (2006-2015). J Eur Acad Dermatol Venereol 32:999–1003. https://doi.org/10.1111/jdv.14601 CrossRefGoogle Scholar
- 47.Zayed H, Effat D, Nawito Z, Abdou AA, el Din MN, el-Refaei S, Amin M, Mohamed Y, Amin A, Wafie A, Abu el-Einin K (2011) Silent central nervous system involvement in Egyptian Behcet’s disease patients: clinical, psychiatric, and neuroimaging evaluation. Clin Rheumatol 30:1173–1180. https://doi.org/10.1007/s10067-011-1725-2 CrossRefGoogle Scholar